Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Bremelanotide acetate by Cosette Pharmaceuticals for Diabetic Nephropathy: Likelihood of Approval
Bremelanotide acetate is under clinical development by Cosette Pharmaceuticals and currently in Phase II for Diabetic Nephropathy. According to GlobalData,...
Data Insights
Bremelanotide acetate by Cosette Pharmaceuticals for Obesity: Likelihood of Approval
Bremelanotide acetate is under clinical development by Cosette Pharmaceuticals and currently in Phase II for Obesity. According to GlobalData, Phase...